Rekah Pharmaceutical Industry Ltd Tangible Net Worth Ratio
Rekah Pharmaceutical Industry Ltd tangible net worth ratio. Rekah Pharmaceutical Industry Ltd (REKA) has a Tangible Net Worth Ratio of 86.3% as of June 2026. This metric is calculated by deducting intangible assets (ILA19.15 Million) from net assets (ILA140.18 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check Rekah Pharmaceutical Industry Ltd (REKA) strategic asset index to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Rekah Pharmaceutical Industry Ltd (2004–2025)
Tangible net worth ratio of Rekah Pharmaceutical Industry Ltd from 2004 to 2025. This chart shows how Rekah Pharmaceutical Industry Ltd's Tangible Net Worth Ratio has changed across 22 annual periods from 2004 to 2025. As of June 2026, the ratio stands at 86.3%, reflecting net assets of ILA140.18 Million with intangible assets of ILA19.15 Million ILA. See REKA working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Rekah Pharmaceutical Industry Ltd Tangible Net Worth Ratio by Year (2004–2025)
Rekah Pharmaceutical Industry Ltd tangible net worth ratio by year from 2004 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Rekah Pharmaceutical Industry Ltd from 2004 to 2025, covering 22 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Rekah Pharmaceutical Industry Ltd stock valuation.
| Year | Tangible NW Ratio | Net Assets (ILA) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 61.0% | ILA144.21 Million | ILA56.27 Million | ILA423.68 Million | ▼ -1.5 pp |
| 2024 | 62.4% | ILA161.98 Million | ILA60.84 Million | ILA447.22 Million | ▼ -17.2 pp |
| 2023 | 79.6% | ILA155.59 Million | ILA31.66 Million | ILA484.72 Million | ▼ -7.6 pp |
| 2022 | 87.2% | ILA162.08 Million | ILA20.67 Million | ILA448.42 Million | ▲ +6.3 pp |
| 2021 | 81.0% | ILA173.06 Million | ILA32.97 Million | ILA437.09 Million | ▼ -16.5 pp |
| 2020 | 97.5% | ILA165.59 Million | ILA4.18 Million | ILA419.69 Million | ▼ -1.0 pp |
| 2019 | 98.4% | ILA155.22 Million | ILA2.44 Million | ILA367.11 Million | ▼ -0.1 pp |
| 2018 | 98.5% | ILA150.66 Million | ILA2.21 Million | ILA300.28 Million | ▲ +0.1 pp |
| 2017 | 98.4% | ILA144.62 Million | ILA2.33 Million | ILA294.95 Million | ▼ -0.4 pp |
| 2016 | 98.8% | ILA105.86 Million | ILA1.26 Million | ILA322.72 Million | ▼ -0.3 pp |
| 2015 | 99.2% | ILA123.66 Million | ILA1.04 Million | ILA323.82 Million | ▲ +0.9 pp |
| 2014 | 98.2% | ILA77.06 Million | ILA1.37 Million | ILA310.11 Million | ▲ +1.5 pp |
| 2013 | 96.7% | ILA79.51 Million | ILA2.61 Million | ILA303.16 Million | ▲ +0.5 pp |
| 2012 | 96.2% | ILA71.17 Million | ILA2.71 Million | ILA298.07 Million | ▲ +1.0 pp |
| 2011 | 95.2% | ILA64.00 Million | ILA3.08 Million | ILA286.99 Million | ▲ +0.7 pp |
| 2010 | 94.5% | ILA63.78 Million | ILA3.51 Million | ILA287.97 Million | ▲ +1.0 pp |
| 2009 | 93.5% | ILA64.15 Million | ILA4.17 Million | ILA278.40 Million | ▲ +1.6 pp |
| 2008 | 91.9% | ILA58.62 Million | ILA4.72 Million | ILA290.50 Million | ▼ -2.3 pp |
| 2007 | 94.2% | ILA67.10 Million | ILA3.89 Million | ILA300.96 Million | ▼ -0.4 pp |
| 2006 | 94.6% | ILA61.54 Million | ILA3.35 Million | ILA296.53 Million | ▼ -1.7 pp |
| 2005 | 96.2% | ILA58.85 Million | ILA2.22 Million | ILA267.00 Million | ▲ +3.0 pp |
| 2004 | 93.2% | ILA48.86 Million | ILA3.30 Million | ILA202.04 Million | — |